Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NALBUPHINE vs NALMEFENE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NALBUPHINE vs NALMEFENE: Safety Overview

Metric NALBUPHINE NALMEFENE
Total FAERS Reports 702 197
Deaths Reported 78 77
Death Rate 11.1% 39.1%
Hospitalizations 95 118
Average Patient Age 42.1 yrs 44.2 yrs
% Female Patients 63.5% 39.3%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 17, 1995
Manufacturer Henry Schein, Inc. Purdue Pharma L.P.
Route INTRAMUSCULAR INTRAMUSCULAR
Marketing Status Discontinued Discontinued